Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Neuroendocrine tumours and genetic disorders 

Neuroendocrine tumours and genetic disorders
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 28 November 2021

Although Siegfried Oberndorfer is rightly credited with introducing the term karzinoide (carcinoma-like) in 1907, T. Langhans had in 1867 described a submucosal tumour that resembled poorly differentiated glandular tissue arranged in ‘nests’ with a rich, thick fibrous stroma (1). Thereafter in 1888, O. Lubarsch reported the post mortem identification of multiple ileal tumours, which he was reluctant to classify as ‘carcinomas’ due to a benign growth pattern appearance (2). In 1890, W.B. Ransom reported similar tumours at autopsy in the region of the ileocoecal valve with associated extensive hepatic tumours, but, in addition, emphasized the associated clinical symptoms, which included diarrhoea and wheezing (3). Nevertheless, despite these early descriptions, it remained for Oberndorfer to published his seminal paper Carcinoid Tumours of the Small Intestine in 1907 and recognize their unique nature; finally defining the lesions as a neoplasm distinct from carcinoma (Fig. 6.1.1) (4).

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.